Pacira BioSciences (PCRX) Stock Chart & Stock Price History → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free PCRX Stock Alerts $26.30 +0.80 (+3.14%) (As of 02:40 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Pacira BioSciences Stock Price Performance5 Day Performance-2.86%1 Month Performance-10.56%3 Month Performance-20.44%6 Month Performance-6.56%Year-To-Date Performance-24.42%1 Year Performance-42.14% Receive PCRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. PCRX Stock Chart for Friday, April, 26, 2024 PCRX Chart by TradingView Pacira BioSciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$25.90$25.50-1.54%$26.00$25.33305,832 shs$1.19 billion04/24/2024$26.81$25.90-3.39%$26.77$25.78359,410 shs$1.20 billion04/23/2024$26.10$26.81+2.72%$27.08$26.19497,168 shs$1.25 billion04/22/2024$26.25$26.10-0.57%$26.67$25.74375,229 shs$1.21 billion04/19/2024$26.10$26.25+0.57%$26.34$25.91448,972 shs$1.22 billion04/18/2024$26.77$26.10-2.50%$26.84$26.08621,147 shs$1.21 billion Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$26.87$26.77-0.37%$27.13$26.36415,509 shs$1.24 billion04/16/2024$26.53$26.87+1.28%$27.63$26.29721,372 shs$1.25 billion04/15/2024$26.83$26.53-1.12%$27.04$25.76604,436 shs$1.23 billion04/12/2024$27.36$26.83-1.94%$27.29$26.61471,620 shs$1.25 billion04/11/2024$27.83$27.36-1.69%$28.09$27.22323,567 shs$1.27 billion04/10/2024$28.52$27.83-2.42%$28.36$27.52444,858 shs$1.33 billion04/09/2024$28.48$28.52+0.14%$28.84$27.99363,923 shs$1.33 billion04/08/2024$28.16$28.48+1.14%$28.73$28.10326,413 shs$1.32 billion04/05/2024$28.40$28.16-0.85%$28.45$27.94415,395 shs$1.31 billion04/04/2024$29.01$28.40-2.10%$29.47$28.18403,192 shs$1.32 billion04/03/2024$28.51$29.01+1.75%$29.12$28.26307,484 shs$1.35 billion04/02/2024$29.15$28.51-2.20%$29.17$28.31477,020 shs$1.33 billion04/01/2024$29.22$29.15-0.24%$29.44$28.43335,223 shs$1.36 billion03/29/2024$29.22$29.22$29.58$28.86569,631 shs$1.36 billion03/28/2024$29.04$29.22+0.62%$29.58$28.86569,630 shs$1.36 billion03/27/2024$28.51$29.04+1.86%$29.30$28.36556,686 shs$1.35 billion03/26/2024$29.23$28.51-2.46%$29.48$28.25531,748 shs$1.33 billion03/25/2024$28.67$29.23+1.95%$29.40$28.60383,010 shs$1.36 billion03/22/2024$29.29$28.67-2.12%$29.45$28.44360,010 shs$1.33 billion03/21/2024$30.02$29.29-2.43%$30.39$29.22535,711 shs$1.36 billion03/20/2024$29.47$30.02+1.87%$30.16$29.08276,537 shs$1.40 billion03/19/2024$29.29$29.47+0.61%$29.72$28.87287,318 shs$1.37 billion03/18/2024$29.41$29.29-0.41%$29.62$28.70327,985 shs$1.36 billion03/15/2024$29.26$29.41+0.51%$29.68$28.821.26 million shs$1.37 billion03/14/2024$30.29$29.26-3.40%$30.27$29.11440,057 shs$1.36 billion03/13/2024$30.56$30.29-0.88%$30.95$29.89369,964 shs$1.41 billion03/12/2024$31.02$30.56-1.48%$31.46$30.51260,206 shs$1.42 billion03/11/2024$31.41$31.02-1.24%$31.45$30.83438,364 shs$1.44 billion03/08/2024$30.64$31.41+2.51%$31.43$30.35527,815 shs$1.46 billion03/07/2024$30.11$30.64+1.76%$31.47$30.25626,719 shs$1.42 billion03/06/2024$29.44$30.11+2.28%$30.16$28.96605,390 shs$1.40 billion03/05/2024$29.20$29.44+0.82%$29.45$28.62452,611 shs$1.37 billion03/04/2024$28.86$29.20+1.18%$29.49$27.89711,605 shs$1.36 billion03/01/2024$29.72$28.86-2.89%$30.00$28.68643,001 shs$1.34 billionMove Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. 02/29/2024$29.91$29.72-0.64%$30.52$28.61768,356 shs$1.38 billion02/28/2024$29.85$29.91+0.20%$30.26$29.30540,621 shs$1.39 billion02/27/2024$29.74$29.85+0.37%$30.20$29.67497,562 shs$1.39 billion02/26/2024$30.04$29.74-1.00%$30.10$29.56351,727 shs$1.39 billion02/23/2024$29.97$30.04+0.23%$30.34$29.46348,523 shs$1.40 billion02/22/2024$29.70$29.97+0.91%$29.98$29.36358,313 shs$1.39 billion02/21/2024$29.86$29.70-0.54%$29.96$29.52299,858 shs$1.38 billion02/20/2024$29.08$29.86+2.68%$29.88$28.86401,451 shs$1.39 billion02/19/2024$29.08$29.08$29.81$29.08350,000 shs$1.35 billion02/16/2024$29.66$29.08-1.96%$29.81$29.08350,012 shs$1.35 billion02/15/2024$29.23$29.66+1.47%$29.93$29.37286,786 shs$1.38 billion02/14/2024$29.21$29.23+0.07%$29.65$29.00286,688 shs$1.36 billion02/13/2024$30.02$29.21-2.70%$29.91$28.94360,643 shs$1.36 billion02/12/2024$28.78$30.02+4.31%$30.04$28.92644,664 shs$1.39 billion02/09/2024$27.70$28.78+3.90%$28.97$27.66604,019 shs$1.34 billion02/08/2024$28.49$27.70-2.77%$28.87$27.371.28 million shs$1.29 billion02/07/2024$30.78$28.49-7.44%$30.15$28.451.05 million shs$1.32 billion02/06/2024$31.14$30.78-1.16%$31.17$30.55494,176 shs$1.43 billion02/05/2024$30.34$31.14+2.64%$31.48$29.98569,169 shs$1.45 billion02/02/2024$31.78$30.34-4.52%$31.15$30.151.22 million shs$1.41 billion02/01/2024$32.59$31.78-2.50%$32.65$31.70539,976 shs$1.48 billion01/31/2024$33.07$32.59-1.45%$34.01$32.49584,715 shs$1.51 billion01/30/2024$32.47$33.07+1.85%$33.64$32.35554,231 shs$1.54 billion01/29/2024$32.05$32.47+1.31%$32.82$31.50375,718 shs$1.51 billion01/26/2024$32.39$32.05-1.05%$32.77$32.03267,499 shs$1.49 billion01/25/2024$32.18$32.39+0.65%$32.78$31.96259,518 shs$1.50 billion Related Companies: Supernus Pharmaceuticals Stock Chart ALX Oncology Stock Chart Agios Pharmaceuticals Stock Chart ADC Therapeutics Stock Chart Atea Pharmaceuticals Stock Chart Nektar Therapeutics Stock Chart Seres Therapeutics Stock Chart Corcept Therapeutics Stock Chart Alkermes Stock Chart Perrigo Stock Chart Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCRX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.